895 related articles for article (PubMed ID: 26590432)
1. The March Toward Malaria Vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
[TBL] [Abstract][Full Text] [Related]
2. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
3. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
4. Live attenuated pre-erythrocytic malaria vaccines.
Keitany GJ; Vignali M; Wang R
Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
[TBL] [Abstract][Full Text] [Related]
5. Current developments in malaria transmission-blocking vaccines.
Stowers A; Carter R
Expert Opin Biol Ther; 2001 Jul; 1(4):619-28. PubMed ID: 11727498
[TBL] [Abstract][Full Text] [Related]
6. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
[TBL] [Abstract][Full Text] [Related]
7. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
Gowda DC; Wu X
Front Immunol; 2018; 9():3006. PubMed ID: 30619355
[TBL] [Abstract][Full Text] [Related]
8. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
[TBL] [Abstract][Full Text] [Related]
9. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
10. Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
[TBL] [Abstract][Full Text] [Related]
11. Vaccines against malaria.
Hill AV
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2806-14. PubMed ID: 21893544
[TBL] [Abstract][Full Text] [Related]
12. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
Epstein JE; Richie TL
Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
Leitner WW; Bergmann-Leitner ES; Angov E
Malar J; 2010 May; 9():145. PubMed ID: 20507620
[TBL] [Abstract][Full Text] [Related]
14. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
16. Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
Fonseca JA; McCaffery JN; Caceres J; Kashentseva E; Singh B; Dmitriev IP; Curiel DT; Moreno A
Vaccine; 2018 May; 36(20):2799-2808. PubMed ID: 29657070
[TBL] [Abstract][Full Text] [Related]
18. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
Jaijyan DK; Singh H; Singh AP
J Biol Chem; 2015 Aug; 290(32):19496-511. PubMed ID: 25960542
[TBL] [Abstract][Full Text] [Related]
19. Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice.
Brod F; Miura K; Taylor I; Li Y; Marini A; Salman AM; Spencer AJ; Long CA; Biswas S
Front Immunol; 2018; 9():2780. PubMed ID: 30564231
[TBL] [Abstract][Full Text] [Related]
20. WITHDRAWN: Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]